OraSure Technologies, Inc.

OSUR Healthcare Medical Instruments & Supplies

OraSure Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $115.0 million, down 38.1% from fiscal 2024. In the quarter to June 2026, revenue fell 1.93%, EPS grew 134.6%, free cash flow fell 1.40% and total debt fell 8.27%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

3.61 0.20 −5.25%
Market cap
$262.8M
P/E
0.0×
Fwd P/E
−3.9×
Dividend yield
—
F-score
3/9
Altman Z
1.47
Beneish M
−2.73
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
Piotroski F-Score
4 3 3 2

+8 more TTM periods

ROE
(14.07%) (21.16%) (18.30%) (15.30%)
ROA
(12.20%) (17.94%) (15.57%) (13.58%)
ROIC
(21.46%) (35.48%) (31.75%) (27.59%)
Return on Tangible Assets
(20.78%) (32.00%) (26.30%) (21.24%)
Average Days of Receivables
88.84 85.31 70.46 70.56
Free Cash Flow per Share
(0.71) (0.70) (0.72) (0.59)
Free Cash Flow
(48.83) (48.66) (53.22) (42.76)
Capital Expenditures
(5.95) (5.48) (4.20) (2.84)
Other line items
Cash ROIC
(10.21%) (9.92%) (9.85%) (7.39%)
Accounts Receivable Turnover
4.22 4.72 5.00 4.91
Accounts Payable Turnover
8.73 7.08 9.10 9.40
Inventory Turnover
2.03 1.98 2.05 2.07
Average Days of Payables
47.50 59.40 35.62 30.99
Days of Inventory on Hand
170.03 169.37 169.66 162.75
Tax Rate
0.00 0.03 0.03 0.04
Research and Development Expense of Revenue
39.69% 41.21% 36.97% 29.59%
Selling, General and Administrative Expense of Revenue
67.73% 65.62% 64.16% 61.49%
Share Based Compensation of Revenue
8.32% 9.05% 8.82% 9.09%
Operating CF/Net income
0.87 0.58 0.71 0.66
Depreciation/Fixed assets
0.25 0.26 0.26 0.25
Capex/Depreciation
(0.62) (0.56) (0.41) (0.28)
Revenue per Share
1.63 1.62 1.57 1.72
Operating CF per Share
(0.62) (0.62) (0.67) (0.55)
Capex per Share
(0.09) (0.08) (0.06) (0.04)
Capex to Sales
0.05 0.05 0.04 0.02

Fold the line items

Columns are period end dates